An open ‐label extension long‐term study of the safety and efficacy of aripiprazole for irritability in children and adolescents with autistic disorder in Japan

ConclusionsAripiprazole was generally safe, well tolerated and effective in the long‐term treatment of irritability associated with AD in Japanese pediatric patients.Clinical Trial Registration: ClinicalTrials.gov (identifier: NCT01617460)

Source: Psychiatry and Clinical Neurosciences - September 1, 2017 Category: Neuroscience Authors: Hironobu Ichikawa, Michio Hiratani, Akihiro Yasuhara, Noa Tsujii, Takashi Oshimo, Hiroaki Ono, Yoshihiro Tadori Tags: Regular Article Source Type: research